Pathophysiology of excess scar production during wound healing
Excessive scarring results from an overabundance of collagen production by fibroblasts in the wound
There is increased production of:
Certain isoforms of TGF-B (Primary mediator) – TGFB1 and B2 increase angiogenesis (proliferation) and collagen deposition (maturation); also prevents collagen breakdown by inhibiting metalloproteinases (collagenase) and upregulating tissue inhibitors of metalloproteinase
Connective tissue growth factor (downstream signaling factor of TGF-B)
PDGF
Tissue inhibitors of metalloproteinases
Decreased production of
Fibroblast growth factor (FGF)
Metalloproteinases (collagenases)
IL-10
Treatment options for keloids and hypertrophic scars
Excess proliferation of fibroblasts and collagen leading to a raised scar that does not grow beyond the boundaries of the original lesion
Keloid
Excess proliferation of fibroblasts and collagen in typically small skin injuries leading to a raised scar that grows beyond the wound margins in a “claw-like” appearance
Exuberant granulation tissue
Formation of excessive amounts of granulation tissue (”proud flesh”)
Desmoid tumor
Fibrous tumors that occur during healing due to abnormal fibroblast proliferation in response to growth factors
Contracture
Contraction of wound edges caused by myofibroblasts. Occurs to a greater extent in healing by secondary-intention than primary intention